1. Li B#, Li H#, Bai Y#, Kirschner-Schwabe R, Yang JJ, Chen Y, Lu G, Tzoneva G, Ma X, Wu T, Li W, Lu H, Ding L, Liang H, Huang X, Yang M, Jin L, Kang H, Chen S, Du A, Shen S, Ding J, Chen H, Chen J, von Stackelberg A, Gu L, Zhang J, Ferrando A, Tang J*, Wang S*, Zhou BB*. Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL. Nature Medicine. 2015 Jun;21(6):563-71. doi: 10.1038/nm.3840（封面文章）
2. Wang D#, Chen Y#, Fang H, Zheng L, Li Y, Yang F, Xu Y, Du L, Zhou BS*, Li H*. Increase of PRPP enhances chemosensitivity of PRPS1 mutant acute lymphoblastic leukemia cells to 5-Fluorouracil. J Cell Mol Med. 2018 Dec;22(12):6202-6212. doi: 10.1111/jcmm.13907
3. Hui Li#, Ning Xiao#, Yingcong Wang#, Rui Wang, Yunfei Chen, Weijuan Pan, Dongmei Liu, Shuangxi Li, Jinxia Sun, Kai Zhang, Yue Sun, Xin Ge*. Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIP5K1γ. Oncogene. 2017 Oct 12;36 (41):5668-5680. doi: 10.1038/onc.2017.166
4. Xiao N#, Li H#, Yu W, Gu C, Fang H, Peng Y, Mao H, Fang Y, Ni W, Yao M*. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation. FASEB J. 2019 Jan;33(1):163-174. doi: 10.1096/fj.201800353R
5. Xiao N#, Li H#, Luo J, Wang R, Chen H, Chen J, Wang P *. Ubiquitin-Specific Protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. Biochem. J. (2012) 441,979-986. doi: 10.1042/BJ20111358
6. Chen YL#, Tang C#, Zhang MY#, Huang WL, Xu Y, Sun HY, Yang F, Song LL, Wang H, Mu LL, Li MH, Zheng WW, Miao Y, Ding LX, Li BS, Shen SH, Liu SL, Li H, Zhu ZQ, Chen HW, Tang ZH, Chen J, Hong DL, Chen HZ*, Duan CW*, Zhou BS *. Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia. Leukemia. 2019 Apr 2. doi: 10.1038/s41375-019-0458-0.
7. Li B#, Brady SW#, Ma X#, Shen S#, Zhang Y#, Li Y#, Szlachta K, Dong L, Liu Y, Yang F, Wang N, Flasch DA, Myers MA, Mulder HL, Ding L, Liu Y, Tian L, Hagiwara K, Xu K, Zhou X, Sioson E, Wang T, Yang L, Zhao J, Zhang H, Shao Y, Sun H, Sun L, Cai J, Sun HY, Lin TN, Du L, Li H, Rusch M, Edmonson MN, Easton J, Zhu X, Zhang J, Cheng C, Raphael BR, Tang J, Downing JR, Alexandrov LB, Zhou BS*, Pui CH*, Yang JJ*, Zhang J*. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood. 2020 Jan 2;135(1):41-55. doi: 10.1182/blood.2019002220.
8. Du L#, Yang F#, Fang H, Sun H, Chen Y, Xu Y, Li H, Zheng L, Zhou BS *. AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells. FASEB J. 2019 Mar;33(3):4525-4537. doi: 10.1096/fj.201801559RR.
9. Xiao N, Li H, Mei W, Cheng J*. SUMOylation Attenuates Human β-Arrestin 2 Inhibition of IL-1R/TRAF6 Signaling. J Biol Chem. 2015 Jan 23;290(4):1927-35. doi: 10.1074/jbc.M114.608703.
10. Liu N, Li H, Li S, Shen M, Xiao N, Chen Y, Wang Y, Wang W, Wang R, Wang Q, Sun J, Wang P *. The Fbw7/hCDC4 tumor suppressor targets pro-proliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J Biol Chem. 2010 Jun 11;285(24):18858-67. doi: 10.1074/jbc.M109.099440.
11. Li L#, Wang M#, Yu G#, Chen P, Li H, Wei D, Zhu J, Xie L, Jia H, Shi J, Li C, Yao W, Wang Y, Gao Q, Jeong LS, Lee HW, Yu J, Hu F, Mei J, Wang P, Chu Y, Qi H, Yang M, Dong Z, Sun Y, Hoffman RM, Jia L.*. Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer. J NATL CANCER I. 2014 May 22;106(6):dju083. doi: 10.1093/jnci/dju083.
12. Pan J, Deng Q, Jiang C, Wang X, Niu T, Li H, Chen T, Jin J, Pan W, Cai X, Yang X, Lu M, Xiao J, Wang P*. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene. 2015 Jul 23;34(30):3957-67. doi: 10.1038/onc.2014.327.
13. Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M *. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-kappaB and MAPK signaling pathways. J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.
导师风采
返回
